Bridgewater Associates’s 1Life Healthcare ONEM Stock Holding History

Bridgewater Associates’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-19,809	Closed	-$331K	–	934
2022 Q4	$331K	Sell	19,809 -240,428	-92%	-$4.06M	﹤0.01%	761
2022 Q3	$4.46M	Sell	260,237 -11,661	-4%	-$183K	0.02%	407
2022 Q2	$2.13M	Buy	271,898 +35,777	+15%	+$307K	0.01%	671
2022 Q1	$2.62M	Buy	236,121 +63,582	+37%	+$712K	0.01%	622
2021 Q4	$3.03M	Buy	172,539 +4,109	+2%	+$79.7K	0.02%	399
2021 Q3	$3.41M	Buy	168,430 +30,626	+22%	+$787K	0.02%	350
2021 Q2	$4.56M	Buy	+137,804	New	+$5.2M	0.03%	348

Bridgewater Associates's ONEM Position: Q1 2023 in Review

Bridgewater Associates sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 19,809 shares — an estimated $331K sold.

Bridgewater Associates first reported a position in ONEM in Q2 2021 and held it in 7 quarters. The position peaked at $4.56M in Q2 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

Bridgewater Associates reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
Bridgewater Associates sold 19,809 1Life Healthcare shares in Q1 2023, an estimated $331K.
Bridgewater Associates first reported a position in 1Life Healthcare in Q2 2021 and held it in 7 quarters.
Bridgewater Associates's 1Life Healthcare position peaked at $4.56M in Q2 2021.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Bridgewater Associates's 13F filing for Q1 2023, filed 12 May 2023.